Clinical trial

Prevacid vs Lifestyle Modifications for the Treatment of LPR

NCT00274339 · Hodge, Kenneth M., M.D., Other · Unknown status

Key facts

NCT number NCT00274339
Title Prevacid vs Lifestyle Modifications for the Treatment of LPR
Official title A Comparison of Prevacid 30mg BID Plus Lifestyle Modifications Versus Lifestyle Modifications Alone for the Treatment of Laryngopharyngeal Reflux (LPR) in Adults
Lead sponsor Hodge, Kenneth M., M.D., Other
Collaborators TAP Pharmaceutical Products Inc. Industry
Status Unknown status
Study type Interventional
Conditions Laryngopharyngeal Reflux
Intervention type Behavioral, Drug
Interventions Prevacid 30mg BID, Lifestyle changes of exercise and diet changes for weight loss and avoidance of reflux inducing foods.
Enrollment 135
Start date Dec 1, 2005
Completion Jun 1, 2008
First posted Jan 10, 2006
Last update posted Jun 25, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies